Clinical trials: Prostatic Neoplasm of Uncertain Behavior
Prostate Cancer, Prostatic Neoplasm
68Ga PSMA in Preprostatectomy Patients
This study investigates if a new drug (PSMA) makes prostate cancer easier to identify in positron-emission tomography (PET) imaging.
- Conditions
- Prostate Cancer, Prostatic Neoplasm, Prostatic Neoplasms, Castration-Resistant, Prostatic Neoplasm of Uncertain Behavior
- Trial name
- NCT03388346
- Testing
- Ga-68 PSMA-HBED-CC PET
- Where
- United States
- Volunteers
- 22 people
- Sponsor
- Michael Graham PhD, MD